Bisodol Antacid

The Origin of Bisodol

Bisodol is a well-established antacid brand that has been a staple in medicine cabinets for decades, particularly in the United Kingdom and Europe. Originally developed as a digestive aid to neutralize stomach acid, it is most commonly available as chewable tablets or powder. The brand's formula is designed to alleviate symptoms of indigestion, heartburn, and trapped wind by combining magnesium carbonate, calcium carbonate, and sodium bicarbonate.

Manufacturing and Global Reach

The production of Bisodol has historically been centered in the United Kingdom, where it remains a popular over-the-counter remedy. While the brand is most prominent in British and Irish markets, it has maintained a consistent presence globally through various pharmaceutical distribution channels. The manufacturing processes adhere to strict medical standards to ensure the efficacy of its acid-neutralizing ingredients.

Corporate Ownership and Heritage

Initially part of the International Chemical Company, the brand has transitioned through several major pharmaceutical portfolios over the years. Today, Bisodol is owned by Teva Pharmaceutical Industries, a global leader in generic and specialty medicines. Teva acquired the brand as part of a larger acquisition of portfolios that included various well-known consumer healthcare products. As of 2024 and looking toward 2026, Teva continues to manage the brand's production and distribution, ensuring its long-term availability in the healthcare market.